ALYSSA WEAVER: Open Payments
NPI 1841911039 · NORTH TONAWANDA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,174 in 64 payments from 17 companies in 2025. Trend: 2023 $2,488 · 2024 $2,045 · 2025 $1,174
Food & beverage: $1,174
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $228 |
| Amgen Inc. | 16 | $193 |
| AstraZeneca Pharmaceuticals LP | 6 | $137 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $102 |
| GlaxoSmithKline, LLC. | 5 | $92 |
| ABBVIE INC. | 3 | $85 |
| Exact Sciences Corporation | 3 | $71 |
| Verona Pharma, Inc. | 3 | $50 |
| Sumitomo Pharma America, Inc. | 2 | $31 |
| Novartis Pharmaceuticals Corporation | 2 | $30 |
Products named: OTEZLA, JARDIANCE, AIRSUPRA, TRELEGY ELLIPTA, UBRELVY, Cologuard Collection Kit, Wegovy, Ohtuvayre.
Industry payments across NY — which companies pay providers there.
